We are live on ! Find out more
PCP

Pacific Capital Partners Portfolio holdings

AUM $116M
1-Year Est. Return 24.59%
This Fund
S&P 500
This Quarter Est. Return
-1.6%
1 Year Est. Return
+24.59%
3 Year Est. Return
+49.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$151M
AUM Growth
-$1.76M
Cap. Flow
+$2.98M
Cap. Flow %
1.97%
Top 10 Hldgs %
48.52%
Holding
63
New
5
Increased
15
Reduced
8
Closed
5
Avg Time Held
2.6 quarters
Top 10 Avg Time Held
2.7 quarters
Top 20 Avg Time Held
2.5 quarters

Top Buys

Rank Stock Value
1
AVTR icon
Avantor
AVTR
+$2.41M
2
ACA icon
Arcosa
ACA
+$2.29M
3
LAB icon
Standard BioTools
LAB
+$1.83M
4
PYPL icon
PayPal
PYPL
+$1.75M
5
EPAM icon
EPAM Systems
EPAM
+$1.07M

Top Sells

Rank Stock Value
1
WWD icon
Woodward
WWD
+$3.83M
2
KKR icon
KKR & Co
KKR
+$2.01M
3
NEE icon
NextEra Energy
NEE
+$1.92M
4
RSG icon
Republic Services
RSG
+$1.42M
5
VSTS icon
Vestis
VSTS
+$964K

Sector Composition

Rank Sector Weight
1 Healthcare 50.01%
2 Industrials 26%
3 Financials 9.58%
4 Materials 5.34%
5 Consumer Discretionary 4.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
SCI icon
26
Service Corp International
SCI
$10.5B
$1.76M 1.16%
24,742
– –
2023 Q3
3 quarters
TMDX icon
27
Transmedics
TMDX
$2.88B
$1.74M 1.15%
11,556
-2,817
-20% -$338K
2023 Q3
3 quarters
BXMT icon
28
Blackstone Mortgage Trust
BXMT
$1.85B
$1.65M 1.1%
95,000
– –
2023 Q3
3 quarters
PYPL icon
29
PayPal
PYPL
$46.1B
$1.6M 1.06%
+27,500
New +$1.75M
2024 Q2
0 quarters
UNH icon
30
UnitedHealth
UNH
$336B
$1.57M 1.04%
3,080
– –
2023 Q3
3 quarters
MRK icon
31
Merck
MRK
$345B
$1.56M 1.03%
12,612
+1,342
+12% +$173K
2023 Q3
3 quarters
CG icon
32
Carlyle Group
CG
$14.2B
$1.53M 1.01%
38,074
+3,274
+9% +$141K
2023 Q3
3 quarters
PRCT icon
33
Procept Biorobotics
PRCT
$1.03B
$1.48M 0.98%
24,299
+2,600
+12% +$155K
2023 Q3
3 quarters
TECK icon
34
Teck Resources
TECK
$33.6B
$1.44M 0.95%
30,000
-2,500
-8% -$123K
2023 Q3
3 quarters
LAB icon
35
Standard BioTools
LAB
$306M
$1.33M 0.88%
+750,000
New +$1.83M
2024 Q2
0 quarters
TMO icon
36
Thermo Fisher Scientific
TMO
$248B
$1.3M 0.86%
2,358
– –
2023 Q3
3 quarters
EXAS
37
DELISTED
Exact Sciences
EXAS
$1.2M 0.8%
28,500
+11,862
+71% +$653K
2023 Q3
3 quarters
STRA icon
38
Strategic Education
STRA
$1.76B
$1.17M 0.77%
10,551
– –
2023 Q3
3 quarters
FTRE icon
39
Fortrea Holdings
FTRE
$1.97B
$1.17M 0.77%
50,000
– –
2024 Q1
1 quarter
AXNX
40
DELISTED
Axonics, Inc. Common Stock
AXNX
$1.13M 0.75%
16,872
– –
2023 Q3
3 quarters
LLY icon
41
Eli Lilly
LLY
$1.02T
$1.13M 0.75%
1,246
– –
2023 Q3
3 quarters
COO icon
42
Cooper Companies
COO
$10.7B
$1.12M 0.74%
12,838
+1,782
+16% +$166K
2023 Q3
3 quarters
BC icon
43
Brunswick
BC
$4.23B
$1.12M 0.74%
15,343
– –
2023 Q3
3 quarters
HUM icon
44
Humana
HUM
$48B
$1.05M 0.69%
2,810
– –
2023 Q3
3 quarters
BSX icon
45
Boston Scientific
BSX
$61.6B
$1.01M 0.67%
13,156
-5,088
-28% -$372K
2023 Q3
3 quarters
EPAM icon
46
EPAM Systems
EPAM
$5.65B
$941K 0.62%
+5,000
New +$1.07M
2024 Q2
0 quarters
CVSA
47
Covista Inc
CVSA
$4.29B
$873K 0.58%
12,803
– –
2023 Q3
3 quarters
PBH icon
48
Prestige Consumer Healthcare
PBH
$2.15B
$861K 0.57%
+12,500
New +$847K
2024 Q2
0 quarters
AMP icon
49
Ameriprise Financial
AMP
$43.7B
$854K 0.56%
1,998
– –
2023 Q3
3 quarters
COLM icon
50
Columbia Sportswear
COLM
$2.92B
$832K 0.55%
10,523
– –
2023 Q3
3 quarters
1
2
3

Similar funds

VWA
Vistica Wealth Advisors Carlsbad, California $116M AUM
JBC
Jefferson Bridge Capital Nashville, Tennessee $115M AUM
IIWM
Investment Insight Wealth Management North Massapequa, New York $115M AUM
JBI
John Boyer Inc Tampa, Florida $115M AUM 28.27% 1-Year Est. Return
BWM
Bluebird Wealth Management Medfield, Massachusetts $115M AUM
SAM
Stembrook Asset Management Red Bank, New Jersey $116M AUM
ACA
Alpha Capital Advisors Bangor, Maine $116M AUM
VFM
Vision Financial Markets Stamford, Connecticut $115M AUM 18.96% 1-Year Est. Return

Pacific Capital Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Pacific Capital Partners held 63 positions worth $151M, down 1.2% from $153M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Pacific Capital Partners's Q2 2024 filing shows 5 new, 15 increased, 8 reduced and 5 closed positions. Its largest new stake was Arcosa: 27,500 shares worth $2.29M. The largest sale was Woodward, an estimated $3.83M.

By sector, the portfolio is most concentrated in Healthcare at 50% of assets, up from 47% a quarter earlier, followed by Industrials and Financials.

  • Pacific Capital Partners's largest Q2 2024 buy was Arcosa: 27,500 shares worth $2.29M.
  • Pacific Capital Partners added most to Avantor in Q2 2024, an estimated $2.41M increase.
  • Pacific Capital Partners's biggest Q2 2024 reduction was Woodward, cutting an estimated $3.83M.
  • Pacific Capital Partners fully exited KKR & Co in Q2 2024, selling an estimated $2.01M.
  • Pacific Capital Partners's ten largest holdings make up 49% of its $151M portfolio in Q2 2024.
  • Pacific Capital Partners opened 5 new positions and closed 5 in Q2 2024.
  • Pacific Capital Partners's portfolio value fell 1.2% quarter-over-quarter to $151M.

Based on Pacific Capital Partners's 13F filing for Q2 2024, filed 8 May 2025.